col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: European Journal of Cancer
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―30 COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) Nicola Fazio, Lorenzo Gervaso, Thorvadur R. Halfdanarson, Anna La Salvia, Johannes Hofland, Jorge Hernando, et al. (+15)
2 [GO] 2021―Jun―26 Covid-19 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up - a monocenter study J.-M. Placke, H. Reis, E. Hadaschik, A. Roesch, D. Schadendorf, I. Stoffels, J. Klode
3 [GO] 2021―Jun―23 BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: a monocentric experience Gabriel Revon-Riviere, Laetitia Ninove, Victoria Min, Angélique Rome, Carole Coze, Arnauld Verschuur, et al. (+2)
4 [GO] 2021―Jun―18 Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer Jérôme Barrière, Daniel Re, Frédéric Peyrade, Michel Carles
5 [GO] 2021―May―28 Impact of COVID-19 on healthcare organization and cancer outcomes A. Bardet, A.M. Fraslin, J. Marghadi, I. Borget, M. Faron, C. Honoré, et al. (+15)
6 [GO] 2021―May―27 Cancer during the COVID-19 pandemic: did we shout loudly enough and did anyone listen? A lasting legacy for nations Pat Price
7 [GO] 2021―May―26 The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey Vincenzo Di Noia, Davide Renna, Vittoria Barberi, Mattia Dicivita, Federica Riva, Giulia Costantini, et al. (+6)
8 [GO] 2021―May―24 Adherence to COVID-19 Vaccines in Cancer Patients: Promote It and Make It Happen! Giuseppe Curigliano, Alexander M.M. Eggermont
9 [GO] 2021―May―17 Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19 Emre Yekedüz, Güngör Utkan, Yüksel Ürün
10 [GO] 2021―May―15 Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19 Caifeng Zou, Yuting Huang, Yuchi Ma, Feng Yang, Deliang Fu
11 [GO] 2021―May―05 Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: a national population-based modelling study in England, UK. Adrian Gheorghe, Camille Maringe, James Spice, Arnie Purushotham, Kalipso Chalkidou, Bernard Rachet, et al. (+2)
12 [GO] 2021―Apr―06 Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study David J. Pinato, Lorenza Scotti, Alessandra Gennari, Emeline Colomba-Blameble, Saoirse Dolly, Angela Loizidou, et al. (+63)
13 [GO] 2021―Apr―02 SARS-CoV-2 vaccination for patients with solid cancer: review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER) David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, Firouze Bani-Sadr, Jean Bourhis, Michel Ducreux, et al. (+18)
14 [GO] 2021―Mar―27 Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients Laura Mansi, Laurie Spehner, Etienne Daguindau, Kevin Bouiller, Hamadi Almotlak, Ulrich Stein, et al. (+13)
15 [GO] 2021―Mar―20 High levels of TNFα in patients with COVID-19 refractory to tocilizumab F.X. Danlos, F. Ackermann, J. Rohmer, M. Roumier, A. Marabelle, J.M. Michot
16 [GO] 2021―Mar―18 Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic Koji Matsuo, Muneaki Shimada, Shinya Matsuzaki, Takayuki Enomoto, Mikio Mikami
17 [GO] 2021―Mar―14 Abscopal anti-tumor effect in a patient with melanoma and COVID-19 Hugo Herrscher, Benoit Sauer, Pierre Truntzer, Caroline Robert
18 [GO] 2021―Feb―27 Seroprevalence of SARs-CoV-2 among the staff and patients of a French cancer centre after first lockdown: the canSEROcov study Sylvain Ladoire, Vincent Goussot, Emilie Redersdorff, Adele Cueff, Elise Ballot, Caroline Truntzer, et al. (+25)
19 [GO] 2021―Feb―27 Immunoglobin G / total antibody testing for SARS-CoV-2: a prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing 3 commercial tests Peter van Dam, Manon Huizing, Ella Roelant, An Hotterbeekx, Fien HR. De Winter, Samir Kumar-Singh, et al. (+11)
20 [GO] 2021―Feb―25 Management of Cancer Patients during the COVID-19 Pandemic: the Italian perspective on the Second Wave Alice Indini, Graziella Pinotti, Fabrizio Artioli, Carlo Aschele, Daniele Bernardi, Alfredo Butera, et al. (+13)
21 [GO] 2021―Feb―25 Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action Chiara Corti, Edoardo Crimini, Paolo Tarantino, Gabriella Pravettoni, Alexander M.M. Eggermont, Suzette Delaloge, Giuseppe Curigliano
22 [GO] 2021―Feb―25 New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of national lockdown Emmanuelle Kempf, Guillaume Lamé, Richard Layese, Sonia Priou, Gilles Chatellier, Hedi Chaieb, et al. (+12)
23 [GO] 2021―Feb―23 Prolonged SARS-CoV-2 viral shedding in patients with solid tumors and associated factors Jacobo Rogado, Pedro Gullón, Berta Obispo, Gloria Serrano, Miguel Ángel Lara
24 [GO] 2021―Feb―19 SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for Immuno-Therapy of Cancer (FITC) Marie-Léa Gauci, Clélia Coutzac, Roch Houot, Aurélien Marabelle, Céleste Lebbé
25 [GO] 2021―Feb―10 2021 Update of the AGIHO guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, et al. (+12)
26 [GO] 2021―Feb―05 Epidemiology and clinical course of SARS-CoV-2 infection in cancer patients in the Veneto Oncology Network: The ROVID Study Valentina Guarneri, Franco Bassan, Vittorina Zagonel, Michele Milella, Marta Zaninelli, Anna Maria Cattelan, et al. (+23)
27 [GO] 2021―Jan―22 Prevention of healthcare-associated respiratory viral infections amongst oncology inpatients: infection prevention outcomes during COVID-19 pandemic Liang En Wee, Edwin Philip Conceicao, Kennedy Yao-Yi Ng, Chee Kian Tham, Indumathi Venkatachalam
28 [GO] 2020―Dec―25 Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era Víctor Rodriguez-Freixinos, Jaume Capdevila, Marianne Pavel, Alia Thawer, Eric Baudin, Dermot O'Toole, et al. (+11)
29 [GO] 2020―Nov―28 SARS-CoV-2 infections in melanoma patients treated with PD-1-inhibitors- a survey of the German ADOREG melanoma registry. Rose K.C. Moritz, Ralf Gutzmer, Lisa Zimmer, Friedegund Meier, Misbah S. Ahmed, Sabine Sell, et al. (+7)
30 [GO] 2020―Oct―20 Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, Alberto Dalla Volta, Pamela Guglielmini, Paolo Zucali, et al. (+19)
31 [GO] 2020―Oct―09 Impact of COVID-19 in Paediatric Early Phase Cancer Clinical Trials in Europe: A report from the Innovative Therapies for Children with Cancer consortium (ITCC) Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, Isabelle Aerts, Alicia Castañeda, Sarah Benezech, et al. (+31)
32 [GO] 2020―Oct―08 Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19) Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, Karine Le Malicot, Juliette Thariat, Guido Ahle, et al. (+547)
33 [GO] 2020―Oct―07 Dutch Oncology COVID-19 Consortium (DOCC): outcome of COVID-19 in patients with cancer in a nationwide cohort study K. de Joode, D.W. Dumoulin, J. Tol, H.M. Westgeest, L.V. Beerepoot, F.W.P.J. van den Berkmortel, et al. (+76)
34 [GO] 2020―Oct―06 A Systematic Review and Meta-Analysis: The Effect of Active Cancer Treatment on Severity of COVID-19 Emre Yekedüz, Güngör Utkan, Yüksel Ürün
35 [GO] 2020―Oct―05 Effects of cancer screening restart strategies after COVID-19 disruption L. Kregting, S. Kaljouw, L. de Jonge, E.E.L. Jansen, E.F.P. Peterse, E.A.M. Heijnsdijk, et al. (+3)
36 [GO] 2020―Oct―05 Impact of COVID-19 on Breast clinic follow ups - a new way forward? C. Norman, L. Ragad, A. Nagarajakumar, H. Irshad, M. Uhercik, I. Giono, et al. (+3)
37 [GO] 2020―Oct―05 Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care during COVID-19 outbreak in North-Eastern Italy. When the going gets tough, the tough gets going! C. Giacometti, M. Maino, A. Ambrosi, S. Zanovello, M. Beda, M. Mion, et al. (+3)
38 [GO] 2020―Oct―05 The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit A. Fancellu, V. Sanna, C. Piredda, L. Ariu, G.Q. Piana, G. Deiana, et al. (+3)
39 [GO] 2020―Oct―05 The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients - a prospective, multicenter cohort study C. Bargon, M. Batenburg, L. van Stam, D.Mink van der Molen, I. van Dam, F. van der Leij, et al. (+10)
40 [GO] 2020―Oct―05 Effect of the COVID-19 pandemic on use of bone-modifying agents for metastatic breast cancer in a UK Oncology centre L. Wang, B. Sribaskaran, M. Ibrahim, M. Karim, A. Neal
41 [GO] 2020―Oct―05 Effects of COVID-19 pandemics in a Breast unit G. Kiziltan, C.B.K. Tumer, C. Ozaslan, O.C. Guler
42 [GO] 2020―Oct―05 Breast referral management and outcome during COVID 19 Pandemic - A UK experience L. Noor, S. Horn, H. Shin, E.J. Turner
43 [GO] 2020―Sep―29 Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic Koji Matsuo, Yongmei Huang, Shinya Matsuzaki, Maximilian Klar, Jason D. Wright
44 [GO] 2020―Sep―22 Repurposing Anticancer Drugs for the Management of COVID-19 Khalid El Bairi, Dario Trapani, Angelica Petrillo, Cécile Le Page, Hanaa Zbakh, Bruno Daniele, et al. (+3)
45 [GO] 2020―Sep―21 Evidence-based Management of COVID-19 in Cancer Patients - Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, et al. (+12)
46 [GO] 2020―Sep―07 Immunological features of coronavirus disease 2019 in patients with cancer Marion Thibaudin, Jean-David Fumet, Marjorie Bon, Léa Hampe, Emeric Limagne, Francois Ghiringhelli
47 [GO] 2020―Sep―06 Risk of death of cancer patients presenting with severe symptoms of infection, with or without documented COVID-19 Souad Assaad, Christine Fuhrmann, Virginie Avrillon, Isabelle Ray-Coquard, Jean-Yves Blay
48 [GO] 2020―Sep―06 Letter of response to comments on: Developing a risk assessment score for cancer patients during COVID-19 pandemic: a war on two fronts. Alice Indini, Erika Rijavec, Michele Ghidini, Monica Cattaneo, Francesco Grossi
49 [GO] 2020―Sep―06 Comment on: Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic Francisco Bautista, Alba Rubio, Jaime Verdú, Anouk Neven, Teresa de Rojas
50 [GO] 2020―Sep―03 High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study Arielle Elkrief, Antoine Desilets, Neha Papneja, Lena Cvetkovic, Catherine Groleau, Yahia Abdelali Lakehal, et al. (+17)
51 [GO] 2020―Sep―02 Mortality in patients with cancer and COVID-19: A systematic review and pooled analysis of 52 studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Marco Romano, Manuela Leone, et al. (+2)
52 [GO] 2020―Aug―11 Favourable outcome of COVID-19 in an ALK-positive NSCLC patient receiving Alectinib Michele Montrone, Annamaria Catino, Vincenzo Ostilio Palmieri, Vito Longo, Domenico Galetta
53 [GO] 2020―Aug―10 High mortality of cancer patients in times of SARS-Cov-2: do not generalize! Peter A. van Dam, Manon Huizing, Kostantinos Papadimitriou, Hans Prenen, Marc Peeters
54 [GO] 2020―Jul―27 COVID-19 outbreak and Phase 1 trials: should we consider a specific patient management? Sophie Postel-Vinay, Christophe Massard, Jean-Charles Soria
55 [GO] 2020―Jul―09 COVID-19, palliative care and public health Gary Rodin, Camilla Zimmermann, Danielle Rodin, Ahmed al-Awamer, Richard Sullivan, Charlotte Chamberlain
56 [GO] 2020―Jul―07 Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer Vasileios Angelis, Zayd Tippu, Kroopa Joshi, Sara Reis, Firza Gronthoud, Charlotte Fribbens, et al. (+14)
57 [GO] 2020―Jul―04 High dose chemotherapy in a patient with COVID-19 Ugo De Giorgi, Chiara Casadei, Giuseppe Bronte, Mattia Altini, Giovani Martinelli
58 [GO] 2020―Jul―04 Impact of the COVID-19 pandemic on cancer treatment: the patients’ perspective K. de Joode, D.W. Dumoulin, V. Engelen, H.J. Bloemendal, M. Verheij, H.W.M. van Laarhoven, et al. (+3)
59 [GO] 2020―Jul―03 Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea S. Lee, A.-R. Lim, M.-J. Kim, Y. Ji Choi, J.W. Kim, K.H. Park, et al. (+2)
60 [GO] 2020―Jun―25 Could anti-CD20 therapy jeopardize the efficacy of a SARS-CoV-2 vaccine? Roch Houot, Ronald Levy, Guillaume Cartron, Philippe Armand
61 [GO] 2020―Jun―17 Immune-related pneumonitis with nivolumab and ipilimumab during the COVID-19 pandemic Ive Lima Souza, Ítalo Fernandes, Patrícia Taranto, Antonio Carlos Buzaid, Gustavo Schvartsman
62 [GO] 2020―Jun―11 Organizational challenges, volumes of oncological activity, and patients' perception during the SARS-CoV-2 epidemic Serena Zuliani, Ilaria Zampiva, Daniela Tregnago, Miriam Casali, Alessandro Cavaliere, Arianna Fumagalli, et al. (+49)
63 [GO] 2020―Jun―10 Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use? Paul Gougis, Charlotte Fenioux, Christian Funck-Brentano, Marianne Veyri, Joseph Gligorov, Caroline Solas, Jean-Philippe Spano
64 [GO] 2020―Jun―08 A review of the International Early Recommendations for Departments Organization and Cancer Management Priorities during the Global COVID-19 Pandemic. Applicability in Low- and Middle-Income Countries Yazid Belkacemi, Noemie Grellier, Sahar Ghith, Kamel Debbi, Gabriele Coraggio, Adda Bounedjar, et al. (+42)
65 [GO] 2020―Jun―07 High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR Souad Assaad, Virginie Avrillon, Marie-Line Fournier, Benedicte Mastroianni, Bruno Russias, Aurélie Swalduz, et al. (+34)
66 [GO] 2020―Jun―06 Sars-CoV-2 infection in cancer patients undergoing active treatment. Analysis of clinical features and predictive factors for severe respiratory failure and death Ramón Yarza, Mateo Bover, Diana Paredes, Flora López-López, Diego Jara-Casas, Alicia Castelo-Loureiro, et al. (+9)
67 [GO] 2020―Jun―04 Immune checkpoint inhibitors: A physiology-driven approach to the treatment of COVID-19 Serena Di Cosimo, Andrea Malfettone, José Manuel Pérez-García, Antonio Llombart-Cussac, Rosalba Miceli, Giuseppe Curigliano, Javier Cortés
68 [GO] 2020―Jun―04 Cancer treatment during COVID-19 pandemic: do not postpone but decide wisely Olivier Huillard, Francois Goldwasser
69 [GO] 2020―Jun―04 Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses Valentina Biagioli, Silvia Belloni, Beatrice Albanesi, Alessio Piredda, Rosario Caruso
70 [GO] 2020―Jun―02 Working in the dark: Interaction with a sub clinical COVID-19 subject and lessons learned Shrinivas Rathod, Shahida Ahmed, Robin Vanstone, Tunji Fatoye, Danielle Desautels, Rashmi Koul
71 [GO] 2020―May―31 Developing a risk assessment score for cancer patients during COVID-19 pandemic Alice Indini, Erika Rijavec, Michele Ghidini, Monica Cattaneo, Francesco Grossi
72 [GO] 2020―May―20 Pausing cancer screening during the SARS-CoV-2 pandemic: should we revisit the recommendations? Moran Amit, Samantha Tam, Tarif Bader, Alex Sorkin, Avi Benov
73 [GO] 2020―May―18 Arterial thrombosis and coronavirus disease 2019 in a patient with cancer Rami Nassabein, Bertrand Routy, Normand Blais, Jean-pierre Ayoub, Mustapha Tehfé
74 [GO] 2020―May―18 Risk of coronavirus disease 2019 in patients treated for cancer: An immune response-based hypothesis Michela Roberto, Fabio Basta, Federica Mazzuca, Giuseppe Curigliano, Paolo Marchetti
75 [GO] 2020―May―16 Comment on ‘Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey” by Alice Indini et al. Alberto Bongiovanni, Laura Mercatali, Valentina Fausti, Toni Ibrahim
76 [GO] 2020―May―12 Cancer treatment during COVID-19 pandemic: do not postpone, do it! Claudia Omarini, Michela Maur, Gabriele Luppi, Franco Narni, Mario Luppi, Massimo Dominici, et al. (+2)
77 [GO] 2020―May―03 SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome Anna M. Di Giacomo, Elisabetta Gambale, Santa Monterisi, Monica Valente, Michele Maio
78 [GO] 2020―Apr―29 The experience on COVID-19 and cancer from an oncology hub institution in Milan, Lombardy Region D. Trapani, A. Marra, G. Curigliano
79 [GO] 2020―Apr―27 Patients with cancer in the era of 2019 novel coronavirus disease Koen J. Hartemink, Alexander C.J. van Akkooi, Aletta P.I. Houwink, Emile E. Voest
80 [GO] 2020―Apr―23 COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors Alessandro Leonetti, Francesco Facchinetti, Teresa Zielli, Elena Brianti, Marcello Tiseo
81 [GO] 2020―Apr―20 Lessons from the COVID-19 pandemic - will virtual patient management reshape uro-oncology in Germany? Severin Rodler, Maria Apfelbeck, Christian Stief, Volker Heinemann, Jozefina Casuscelli
82 [GO] 2020―Apr―18 Cancer and COVID-19; how do we manage cancer optimally through a public health crisis? Eduard Vrdoljak, Richard Sullivan, Mark Lawler
83 [GO] 2020―Apr―11 Managing patients with cancer in the COVID-19 era Ling Peng, Sladjana Zagorac, Justin Stebbing
84 [GO] 2020―Apr―07 A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19-positive patients with cancer Florian Scotté, Etienne Minvielle, Olivier Mir, Fabrice André, Fabrice Barlesi, Jean-Charles Soria
85 [GO] 2020―Apr―07 Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment Ondrej Hrusak, Tomas Kalina, Joshua Wolf, Adriana Balduzzi, Massimo Provenzi, Carmelo Rizzari, et al. (+35)
86 [GO] 2020―Apr―06 Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic Paolo Tarantino, Dario Trapani, Giuseppe Curigliano
87 [GO] 2020―Apr―06 Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey Alice Indini, Carlo Aschele, Luigi Cavanna, Mario Clerico, Bruno Daniele, Giammaria Fiorentini, et al. (+9)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec